BCL3 and colorectal carcinoma: By preferentially diverting β-catenin/TCF-mediated transcription towards the stemness genes LGR5 and ASCL2 over some of the more classical Wnt targets such as cyclin D1 and MYC, it appears that BCL-3 may be driving CRC cells towards a stem-cell phenotype.